yes that is good and they also tweeted the link, i think they will update us soon, I think we re the only listed company in the trial based on the email i received __ ”...Thank you for your contact.
St. George Street can confirm the clinical trial is ongoing and will make all necessary disclosures regarding the trial and its completion to Vela Technologies and its shareholders..."
worth a read--”..But there is still a vast amount of work for researchers and clinicians to do. First, they need to determine how well the vaccines work in people who are at high risk of COVID-19, including older individuals, people with obesity and those with diabetes...”,___ that is where our trial will help
For mode they actually had a nice rns recently, but the sp is too expensive there, much better to buy Vela -:)
C&P= As part of its Mode for Business offering, Mode operates a payment processing, marketing and advertising business, for UK merchants aiming to access overseas markets such as China. The technology provides a payment gateway solution for UK merchants allowing them to accept payments from WeChat Pay and Alipay - the two largest payment platforms in the world. This supports Mode's vision of removing friction in the global payments market and enables UK merchants to engage with Chinese shoppers.
TP, I posted the link few days ago, and it is still there, has not been deleted 40pts on 19th Nov, i am sure it is much more now as it takes time, between recruitment at the hospital and reporting to SGSC, link attached___https://twitter.com/st_capital/status/1329478169687191552
here is the link again for people who just joined, you can see why they are backing the trial (the International Diabetes Federation ranked the UAE 16th globally in diabetes prevalence, with an estimated 19 percent of the UAE population living with diabetes...)
In any case our trial will be completed in much faster pace now as more units started to recruit and more admissions happening during the winter unfortunately (seasonal pattern). For the AZ agreement someone asked what happens after phase II so looking at the rns paragraph ”...Following clinical development, AstraZeneca has a right of first negotiation to take the compounds back for further development through to Phase III and commercialisation. Alternatively, rights may be explored with a third party...” which translates into (buy back by AZ for further development or a third party) so it is a win/win for SGSC. Anyone remembers AZ financing REDX with £350M over 3 years to further develop one of their products, which seems to be their usual working pattern (redx sp rose 250% this day off my head)
on 2nd Nov they recruited 15 pts, 19th Nov 40 pts, and more hospitals now joining the trial, confirms my estimation, within 4-6 weeks or sooner should have recruited the required number of 150